Trulieve Cannabis Corp
Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One b… Read more
Trulieve Cannabis Corp (TCNNF) - Net Assets
Latest net assets as of September 2025: $1.19 Billion USD
Based on the latest financial reports, Trulieve Cannabis Corp (TCNNF) has net assets worth $1.19 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.94 Billion) and total liabilities ($1.76 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.19 Billion |
| % of Total Assets | 40.33% |
| Annual Growth Rate | N/A |
| 5-Year Change | 178.86% |
| 10-Year Change | N/A |
| Growth Volatility | 144.46 |
Trulieve Cannabis Corp - Net Assets Trend (2016–2024)
This chart illustrates how Trulieve Cannabis Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Trulieve Cannabis Corp (2016–2024)
The table below shows the annual net assets of Trulieve Cannabis Corp from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.25 Billion | -11.33% |
| 2023-12-31 | $1.41 Billion | -26.93% |
| 2022-12-31 | $1.93 Billion | -10.23% |
| 2021-12-31 | $2.15 Billion | +379.43% |
| 2020-12-31 | $447.90 Million | +58.63% |
| 2019-12-31 | $282.36 Million | +170.93% |
| 2018-12-31 | $104.22 Million | +37371.08% |
| 2017-12-31 | $-279.62K | -22.86% |
| 2016-12-31 | $-227.60K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Trulieve Cannabis Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 79183680500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $2.06 Billion | 163.09% |
| Total Equity | $1.26 Billion | 100.00% |
Trulieve Cannabis Corp Competitors by Market Cap
The table below lists competitors of Trulieve Cannabis Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Opthea Ltd
NASDAQ:OPT
|
$524.82 Million |
|
mBank S.A.
PINK:MBAKF
|
$524.85 Million |
|
Shandong Intco Recycling Resources Co Ltd
SHG:688087
|
$524.90 Million |
|
Suzhou New District Hi Tech Industrial Co Ltd
SHG:600736
|
$524.98 Million |
|
Irish Residential Properties REIT Plc
PINK:RSHPF
|
$524.65 Million |
|
Intellian Technologies Inc
KQ:189300
|
$524.59 Million |
|
Wafer Works
TWO:6182
|
$524.54 Million |
|
VP Bank AG
SW:VPBN
|
$524.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Trulieve Cannabis Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,414,473,000 to 1,261,288,000, a change of -153,185,000 (-10.8%).
- Net loss of 155,105,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-155.10 Million | -12.3% |
| Other Changes | $1.92 Million | +0.15% |
| Total Change | $- | -10.83% |
Book Value vs Market Value Analysis
This analysis compares Trulieve Cannabis Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.49x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.00 | $3.23 | x |
| 2018-12-31 | $0.95 | $3.23 | x |
| 2019-12-31 | $2.56 | $3.23 | x |
| 2020-12-31 | $3.75 | $3.23 | x |
| 2021-12-31 | $11.89 | $3.23 | x |
| 2022-12-31 | $10.38 | $3.23 | x |
| 2023-12-31 | $7.60 | $3.23 | x |
| 2024-12-31 | $6.60 | $3.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Trulieve Cannabis Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.30%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.07%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 2.28x
- Recent ROE (-12.30%) is below the historical average (6.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $15.43K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.39K |
| 2018 | 41.23% | 41.79% | 0.63x | 1.56x | $32.55 Million |
| 2019 | 63.05% | 70.42% | 0.43x | 2.09x | $149.80 Million |
| 2020 | 14.07% | 12.08% | 0.64x | 1.82x | $18.21 Million |
| 2021 | 0.84% | 1.92% | 0.28x | 1.59x | $-196.55 Million |
| 2022 | -12.74% | -19.85% | 0.36x | 1.76x | $-439.22 Million |
| 2023 | -37.24% | -46.65% | 0.41x | 1.93x | $-668.24 Million |
| 2024 | -12.30% | -13.07% | 0.41x | 2.28x | $-281.23 Million |
Industry Comparison
This section compares Trulieve Cannabis Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Trulieve Cannabis Corp (TCNNF) | $1.19 Billion | 0.00% | 1.48x | $524.69 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |